Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nath Bio-Genes (India) Limited (NSE: NATHBIOGEN), ISIN INE448G01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NATHBIOGEN last traded at ₹135.21 (-2.20%), with a 52-week range of ₹126.15 to ₹204.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 45.60%, FIIs 0.18%, DIIs 0.01%, mutual funds 0.01%.
EquiSense Score (ECS): 60/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.